Molecular characterization of a new SARS-CoV-2 recombinant cluster XAG identified in Brazil
- PMID: 36250091
- PMCID: PMC9554242
- DOI: 10.3389/fmed.2022.1008600
Molecular characterization of a new SARS-CoV-2 recombinant cluster XAG identified in Brazil
Abstract
Recombination events have been described in the Coronaviridae family. Since the beginning of the SARS-CoV-2 pandemic, a variable degree of selection pressure has acted upon the virus, generating new strains with increased fitness in terms of viral transmission and antibody scape. Most of the SC2 variants of concern (VOC) detected so far carry a combination of key amino acid changes and indels. Recombination may also reshuffle existing genetic profiles of distinct strains, potentially giving origin to recombinant strains with altered phenotypes. However, co-infection and recombination events are challenging to detect and require in-depth curation of assembled genomes and sequencing reds. Here, we present the molecular characterization of a new SARS-CoV-2 recombinant between BA.1.1 and BA.2.23 Omicron lineages identified in Brazil. We characterized four mutations that had not been previously described in any of the recombinants already identified worldwide and described the likely breaking points. Moreover, through phylogenetic analysis, we showed that the newly named XAG lineage groups in a highly supported monophyletic clade confirmed its common evolutionary history from parental Omicron lineages and other recombinants already described. These observations were only possible thanks to the joint effort of bioinformatics tools auxiliary in genomic surveillance and the manual curation of experienced personnel, demonstrating the importance of genetic, and bioinformatic knowledge in genomics.
Keywords: SARS-CoV-2; XAG; genomic surveillance; omicron; recombinant; variants.
Copyright © 2022 Silva, Salvato, Gregianini, Gomes, Pereira, de Oliveira, de Menezes, Barcellos, Godinho, Riediger, Debur, de Oliveira, Ribeiro-Rodrigues, Miyajima, Dias, Abbud, Monte-Neto, Calzavara-Silva, Siqueira, Wallau, Resende, Fernandes and Alves.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures




Similar articles
-
SARS-CoV-2 Omicron BA.1, BA.2, and XAG identification during routine surveillance on a university campus in Belo Horizonte, Brazil, 2022.Braz J Microbiol. 2022 Dec;53(4):2009-2014. doi: 10.1007/s42770-022-00848-5. Epub 2022 Oct 22. Braz J Microbiol. 2022. PMID: 36272063 Free PMC article.
-
Unraveling the genetic evolution of SARS-CoV-2 Recombinants using mutational dynamics across the different lineages.Front Med (Lausanne). 2024 Jan 15;10:1294699. doi: 10.3389/fmed.2023.1294699. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38288302 Free PMC article.
-
Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.Virol J. 2021 Nov 17;18(1):222. doi: 10.1186/s12985-021-01690-1. Virol J. 2021. PMID: 34789293 Free PMC article.
-
Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.J Med Virol. 2023 Jan;95(1):e28366. doi: 10.1002/jmv.28366. J Med Virol. 2023. PMID: 36458547 Free PMC article. Review.
-
The Rise and Fall of SARS-CoV-2 Variants and Ongoing Diversification of Omicron.Viruses. 2022 Sep 10;14(9):2009. doi: 10.3390/v14092009. Viruses. 2022. PMID: 36146815 Free PMC article. Review.
Cited by
-
The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence.Heliyon. 2022 Dec;8(12):e12650. doi: 10.1016/j.heliyon.2022.e12650. Epub 2022 Dec 24. Heliyon. 2022. PMID: 36590492 Free PMC article.
-
Clinical characteristic and outcomes of pregnant women with COVID-19: The PROUDEST prospective cohort study.PLoS One. 2025 Jul 3;20(7):e0327174. doi: 10.1371/journal.pone.0327174. eCollection 2025. PLoS One. 2025. PMID: 40608806 Free PMC article.
-
Diversity of Omicron sublineages and clinical characteristics in hospitalized patients in the southernmost state of Brazil.BMC Infect Dis. 2024 Feb 13;24(1):193. doi: 10.1186/s12879-024-09089-3. BMC Infect Dis. 2024. PMID: 38350887 Free PMC article.
-
SARS-CoV-2 Genomic Surveillance in Brazil: A Systematic Review with Scientometric Analysis.Viruses. 2022 Dec 5;14(12):2715. doi: 10.3390/v14122715. Viruses. 2022. PMID: 36560720 Free PMC article.
-
Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil.Viruses. 2023 Feb 20;15(2):585. doi: 10.3390/v15020585. Viruses. 2023. PMID: 36851799 Free PMC article.
References
-
- World Health Organization. Genomic Sequencing of SARS-CoV-2: A Guide to Implementation for Maximum Impact on Public Health. Geneva: WHO; (2021).
LinkOut - more resources
Full Text Sources
Miscellaneous